Stem Cell News Blog

Stem cell experts say they are making progress in developing new cures for disease and illnesses, but that it will take time and money.

WASHINGTON (CNS) — Stem-cell research is once again making news in Congress and the courts. But this time, it’s on the sports pages too.

Stem cell research and regenerative medicine has long held the potential to treat serious medical conditions, but only recently has the industry as a whole begun to take shape. What was once confined within the realm of research and academia is now attracting the interest of corporations and philanthropists who are investing large amounts of money into this promising science.

Carnegie Mellon University biologists have developed an MRI-based technique that allows researchers to non-invasively follow neural stem cells in vivo.

Using a patient’s own stem cells, researchers at Johns Hopkins have corrected the genetic alteration that causes sickle cell disease (SCD), a painful, disabling inherited blood disorder that affects mostly African-Americans. The corrected stem cells were coaxed into immature red blood cells in a test tube that then turned on a normal version of the gene…

Senior plastic surgeons have issued a warning over a new breast enlargement procedure being offered by private UK clinics.

Six leaders in stem cell research from the Cedars-Sinai Regenerative Medicine Institute will be key presenters at the world’s largest interdisciplinary stem cell meeting Oct. 3-5 in Pasadena, Calif.

Cardiologists at Austin Heart are looking for patients to take part in an adult stem cell trial for treatment of peripheral arterial disease. And the second annual Stem Cell Symposium happens in Austin on Friday.

Biologists have developed an MRI-based technique that allows researchers to non-invasively follow neural stem cells in vivo. The recently patented technology could be used to further the study of neural stem cells and inform the development of new treatments for brain injury caused by trauma, stroke, Parkinson’s disease and other neurological disorders.

Stem cell research and regenerative medicine has long held the potential to treat serious medical conditions, but only recently has the industry as a whole begun to take shape. What was once confined within the realm of research and academia is now attracting the interest of corporations and philanthropists who are investing large amounts of money into this promising science.